Home1099 • HKG
add
Sinopharm Group Co Ltd
Previous close
$21.75
Day range
$21.35 - $22.15
Year range
$17.44 - $28.45
Market cap
67.25B HKD
Avg Volume
5.19M
P/E ratio
6.87
Dividend yield
4.38%
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 150.65B | 3.35% |
Operating expense | 5.55B | 2.03% |
Net income | 2.96B | 10.82% |
Net profit margin | 1.96 | 7.10% |
Earnings per share | — | — |
EBITDA | 8.33B | -1.40% |
Effective tax rate | 23.78% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 63.81B | 9.22% |
Total assets | 383.39B | 5.10% |
Total liabilities | 263.08B | 3.29% |
Total equity | 120.32B | — |
Shares outstanding | 3.12B | — |
Price to book | 0.91 | — |
Return on assets | 4.83% | — |
Return on capital | 9.74% | — |
Cash Flow
Net change in cash
(CNY) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 2.96B | 10.82% |
Cash from operations | 56.84B | 8.50% |
Cash from investing | -957.38M | 62.81% |
Cash from financing | -25.33B | -8.21% |
Net change in cash | 30.55B | 15.75% |
Free cash flow | 37.43B | 28.69% |
About
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Founded
2003
Website
Employees
115,959